There were 176 press releases posted in the last 24 hours and 170,703 in the last 365 days.

Antidiarrheal Drug Market Major Competitor Analysis - GlaxoSmithKline, Actelion, Perrigo, Lupin and Glenmark

TheBusinessResearchCompany.com offers Antidiarrhoeals Drugs Global Market Report 2019 from its research database.

The global antidiarrhoeals market was valued at about $0.24 billion in 2018 and is expected to grow to $0.27 billion at a CAGR of 2.7% through 2022.”
— Abdul Wasay

LONDON, GREATER LONDON, UK, November 28, 2019 /EINPresswire.com/ -- The global antidiarrheals market is expected to grow to $0.27 billion at a rate of about 2.7% through 2022. Rise in the number of diarrhea cases significantly contributes to the growth of antidiarrheal drugs market. According to UNICEF, as of 2016, diarrhea was the second leading cause of death among children under the age of 5 years that is responsible for killing 760,000 children every year. Increasing number of diarrheal cases increases the demand for antidiarrheal drugs. Increase in the use of biologics medicines poses to be a restraint to the antidiarrheal market.

The antidiarrheal drugs market consists of sale of antidiarrheal drugs and related services. Diarrhea is a disease affecting digestive parts of the body such as stomach, large intestine and rectum, esophagus, liver, gallbladder and pancreas and causes loose, watery bowel movements. Loperamide and bismuth subsalicylate are some examples of antidiarrheal drugs.

Request For A Free Sample For The Global Antidiarrheals Drugs Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2464&type=smp

The global antidiarrheals drugs market is further segmented based on type and geography.

By Type - The antidiarrheals drugs market is segmented by drug class into mucosal protectants and motility modifying drugs.

By Geography - The global antidiarrheals drugs is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Trends In The Antidiarrheals Drugs Market
Major companies in the antidiarrheal drug market are merging with other companies in the market to increase their reach and market share. Companies merge with or acquire other companies to expand their market share, diversify their product portfolio, or acquire new technologies.

Potential Opportunities In The Antidiarrheals Drugs Market
With growing population worldwide and increasing academia-industry collaborations to develop new drugs for treatment, the scope and potential for the global antidiarrheals drugs market is expected to significantly rise in the forecast period.

Major players in the market are GlaxoSmithKline, Actelion, Perrigo, Lupin and Glenmark Pharmaceuticals.
Antidiarrheals Drugs Global Market Report 2019 is one of a series of new reports from The Business Research Company that provides antidiarrheals drugs market overviews, analyzes and forecasts antidiarrheals drugs market size and growth for the global antidiarrheals drugs market, antidiarrheals drugs market share, antidiarrheals drugs market players, antidiarrheals drugs market size, antidiarrheals drugs market segments and geographies, antidiarrheals drugs market trends, antidiarrheals drugs market drivers and antidiarrheals drugs market restraints, antidiarrheals drugs market’s leading competitors’ revenues, profiles and market shares. The antidiarrheals drugs market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Where To Learn More

Read Antidiarrheals Drugs Global Market Report 2019 from The Business Research Company for information on the following:

Markets Covered: global antidiarrheals drugs market

Data Segmentations: antidiarrheals drugs market size, global and by country; historic and forecast size, and growth rates for the world, 7 regions and 12 countries

Antidiarrheals Drugs Market Organizations Covered: GlaxoSmithKline, Actelion, Perrigo, Lupin and Glenmark Pharmaceuticals

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Time Series: Five years historic (2014-18) and forecast (2018-22).

Other Information And Analyses: PESTEL analysis, antidiarrheals drugs market customer information, antidiarrheals drugs market product/service analysis – product examples, antidiarrheals drugs market trends and opportunities, drivers and restraints, key mergers and acquisitions, key metrics covered: number of enterprises, number of employees, global antidiarrheals drugs market in 2019 - countries offering most new opportunities

Sourcing and Referencing: Data and analysis throughout the report are sourced using end notes.

Strategies For Participants In The Antidiarrheals Drugs Industry: the report explains a number of strategies for companies in the antidiarrheals drugs market, based on industry trends and company analysis.

Opportunities For Companies In The Antidiarrheals Drugs Sector: The report reveals where the global antidiarrheals drugs industry will put on most $ sales up to 2022.

Interested to know more about The Business Research Company?
The Business Research Company has published over 300 industry reports, covering over 2400 market segments and 56 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. Here is a list of reports from The Business Research Company similar to Antidiarrheals Drugs Global Market Report 2019:

Gastrointestinal Drugs Global Market Report 2019 @ https://www.thebusinessresearchcompany.com/report/gastrointestinal-drugs-global-market-report

Metabolic Disorders Drugs Global Market Report 2019 @ https://www.thebusinessresearchcompany.com/report/metabolic-disorders-drugs-global-market-report

Pharmaceutical Drugs Market By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs) - Global Forecast To 2022

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.